Načítá se...
Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice
Liver fibrosis occurs in response to chronic damage and inflammation to the liver. Leaving untreated, it can lead to decreased liver function and can eventually progress to cirrhosis, a more advanced and irreversible state of liver damage. Clinical investigations showed that chronic liver disease as...
Uloženo v:
| Vydáno v: | Frontiers in Pharmacology |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Článek |
| Vydáno: |
Frontiers Media S.A.
2024-05-01
|
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1385330/full |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|